| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000029242 |
| Receipt No. | R000033423 |
| Official scientific title of the study | The effect of intake of Peucedanum japonicum on vasceral fat. |
| Date of disclosure of the study information | 2017/10/20 |
| Last modified on | 2018/04/18 (Ver. 4) |
| Basic information | ||
| Official scientific title of the study | The effect of intake of Peucedanum japonicum on vasceral fat. | |
| Title of the study (Brief title) | The effect of intake of Peucedanum japonicum on vasceral fat. | |
| Region |
|
|
| Condition | ||
| Condition | obesity | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | We will examine changes in visceral fat of subjects who take Peucedanum japonicum for 12 weeks. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Time course of abdominal visceral fat area by CT examination.
(Before intake, after intake 4weeks, after intake 8weeks and after intake 12weeks.) |
| Key secondary outcomes | Biochemical indicator, Body composition
(Before intake, after intake 4weeks, after intake 8weeks and after intake 12weeks.) |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | Subjects takes the 12-week test food. The evaluation is carried out every four weeks. | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1. Japanese men and women from 20 years old to 80 years old
2. Those who fully understand and document agreed by free will of the subject person was obtained after having received a sufficient explanation of the study 3. BMI >=25kg/m2, <30kg/m2 4. Visceral fat area >=80cm2 |
|||
| Key exclusion criteria | 1. Taking drugs that may affect obesity, hyperlipidemia or lipid metabolism
2. Taking sapplement or functional foods that may affect obesity, hyperlipidemia or lipid metabolism 3. Those who are routinely regular use "Peucedanum japonicum" 4. Embedding metal in the abdomen 5. Severe hepatic disorder, kidney / heart disease, organ disorder, diabetes, other serious diseases 6. It is diagnosed as familial hyperlipidemia 7. Have a history of food allergy 8. More than 500 ml of beer per day (25 ml in terms of alcohol) 9. There are more than 20 smokers on average per day 10. During pregnancy, pregnancy, and also during pregnancy wishing for pregnancy 11. Participating in other clinical trials or planning to participate 12. Other, who investigators were ineligible |
|||
| Target sample size | 25 | |||
| Research contact person | |
| Name of lead principal investigator | Satoshi Ohno |
| Organization | Osaka University Graduate School of Medicine |
| Division name | Department of Integrative Medicine |
| Address | 2-2, Yamadaoka, Suita, OSAKA |
| TEL | 06-6879-3498 |
| ohno@cam.med.osaka-u.ac.jp | |
| Public contact | |
| Name of contact person | Miki Sakaue |
| Organization | Osaka University Graduate School of Medicine |
| Division name | Department of Integrative Medicine |
| Address | 2-2, Yamadaoka, Suita, OSAKA |
| TEL | 06-6879-3498 |
| Homepage URL | |
| mikity@cam.med.osaka-u.ac.jp | |
| Sponsor | |
| Institute | Department of Integrative Medicine, Osaka University Graduate School of Medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Okinawa TLO Ltd. |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000033423 |